SUMMARY A 17 month old girl with tricuspid atresia, ventricular septal defect, subvalvar and valvar pulmonary stenosis, and increasing cyanosis had angiographic evidence of proximal stenosis of a right modified ( artery pressure was 10/7 mm Hg (mean 8) with a simultaneous aortic pressure of 100/50 mm Hg (mean 60). Angiography showed moderate stenosis of the modified Blalock-Taussig shunt at the site of the proximal anastomosis (fig 1) . There was acquired pulmonary atresia and the pulmonary arteries were of normal size with no evidence of localised stenosis or kinking. Balloon dilatation was performed. She was systemically heparinised with 50 IU/kg. A straight 0-020 inch exchange guide wire was passed from the femoral artery, into the descending aorta, through the shunt, and placed in the distal right lower lobe branch pulmonary artery. A Schneider balloon catheter (6 mm diameter, 15 mm balloon length) on a 5 French shaft was positioned across the site of the proximal stenosis and inflated twice. There were no complications either during or after inflation. Repeat angiography showed satisfactory relief of the proximal stenotic site. Pulse oximetry showed a transcutaneous oxygen saturation of 80% after the procedure. There were no early complications after this procedure and treatment with aspirin (10 mg/kg/ 24h) and dipyridamole (6 mg/kg/24h) was started.
Four months later, when she was 21 months old, she was less cyanosed. At repeat cardiac catheterisation the aortic oxygen saturation was 76%. Repeat angiography showed that the proximal anastomotic site was patent with no evidence of restenosis or formation of an aneurysm (fig 2) . Balloon angioplasty achieved adequate palliation for four months without complications. There was an improvement in cyanosis, haemoglobin concentrations did not increase, and angiography did not show early restenosis or aneurysm formation. She remains suitable for a Fontan-type procedure.
There were no technical problems or complications associated with this procedure. The choice of balloon size was related to the size of the prosthetic shunt rather than specific angiographic measurements. For dilatation of a classic Blalock-Taussig shunt Fischer et al measured the diameter of the shunt immediately proximal to the stenosis and they found that a balloon with a diameter ofequal size was ineffective; they used a balloon with a diameter that was 2 mm larger and a balloon to shunt ratio of 150%.' We recommend caution in using such a ratio for dilating prosthetic materials. Aneurysm formation and vessel and graft rupture are potential complications.
We believe that balloon angioplasty of stenosed modified Blalock-Taussig shunts is feasible and safe and may produce palliation in selected patients. Until further studies have been performed we advise caution in using balloon diameters that are larger than the shunt diameter. 
